159 Seropositive persons should be evaluated for severity of immune dysfunction and screened for other infectious diseases such as tuberculosis. All seropositive individuals should be encouraged to notify sex partners, persons with whom injection needles have been shared, and others at risk of exposure. Seropositive cases should be reported confidentially or anonymously to public health officials in accordance with local regulations. Persons with nonreactive test results should be informed that the risk of acquiring subsequent HIV infection can be prevented by maintaining monogamous sexual relationships with uninfected partners. The frequency of repeat testing of seronegative individuals is a matter of clinical discretion.
Periodic testing is most important in patients who continue high-risk activities.
This site produced by the Journal of the American Medical Association with support from Ortho-McNeil Pharmaceutical and Advanced Care Products. All rights reserved.